ClinicalTrials.Veeva

Menu

Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Primary Open Angle Glaucoma

Study type

Observational

Funder types

Other

Identifiers

NCT00773123
08-0342

Details and patient eligibility

About

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL and ganglion cell layer thickness.

Enrollment

300 estimated patients

Sex

All

Ages

10 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria:

  • Evidence of retinal disease
  • Neovascular glaucoma
  • Secondary glaucoma due to intraocular inflammation
  • Lens induced glaucoma
  • Tumor induced glaucoma

Trial design

300 participants in 2 patient groups

1
Description:
Primary open angle glaucoma
2
Description:
Normal controls

Trial contacts and locations

1

Loading...

Central trial contact

Sung Yong Kang, MD; Chan Yun Kim, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems